Medicenna Therapeutics Corp Annual Shareholders Meeting Transcript
Ladies and gentlemen, welcome to the Annual Meeting of Shareholders of Medicenna Therapeutics Corp. Please note the meeting is being recorded. I would like to introduce Dr. Fahar Merchant, Chairman and Board of Director -- of the Board of Directors. Dr. Merchant, please go ahead.
Thank you. The Annual Meeting of Shareholders of Medicenna Therapeutics Corp. will now come to order. My name is Dr. Fahar Merchant, and I'm Chairman of the Board of Directors of the Corporation. I will preside as Chairman of the meeting, and I hereby appoint Mr. Charles-Antoine Soulière of McCarthy Tetrault LLP to act as Secretary of the meeting.
To mitigate risks to the health and safety of our communities, shareholders, employees and other stakeholders resulting from the unprecedented public health impact of COVID-19, we have opted for a virtual-only annual general meeting. In making the decision to hold a virtual meeting, it was paramount to ensure that shareholder rights were protected.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |